MugeGCalikogluMD

PubMed

• Are individual-level risk factors for gastroschisis modified by neighborhood-level socioeconomic factors?
  Dayna T Neo, Chantel L Martin, Suzan L Carmichael, Muge Gucsavas-Calikoglu, Kristin M Conway, Shannon Pruitt Evans, Marcia L Feldkamp, Suzanne M Gilboa, Tabassum Z Ins...> ;Birth Defects Research. 2023 Sep 1
• 2 citations
  Neighborhood-level Socioeconomic Position During Early Pregnancy and Risk of Gastroschisis.
  Dayna T Neo, Tania A Desrosiers, Chantel L Martin, Suzan L Carmichael, Muge Gucsavas-Calikoglu, Kristin M Conway, Shannon Pruitt Evans, Marcia L Feldkamp, Suzanne M Gi...> ;Epidemiology. 2023 Jul 1
• 39 citations
  An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn Screening
  Laura V. Milko, Julianne M. O’Daniel, Daniela M. DeCristo, Stephanie B. Crowley, Ann Katherine M. Foreman, Kathleen Wallace, Lonna Mollison, Natasha T. Strande, Zahra ...> ;The Journal of Pediatrics. 2019 Mar 7
• 108 citations
  Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations
  Jeffrey M. Chinsky, Rani H. Singh, Can Ficicioglu, Clara D.M. van Karnebeek, Markus Grompe, Grant A. Mitchell, Susan E. Waisbren, Muge Gucsavas-Calikoglu, Melissa P. W...> ;Genetics in Medicine. 2017 Aug 3
• Co-occurring Down syndrome and SUCLA2-related mitochondrial depletion syndrome
  Natario L. Couser, Daniel S. Marchuk, Laurie D. Smith, Alexandra Arreola, Kathleen Kaiser-Rogers, Joseph Muenzer, Arti Pandya, Muge Gucsavas-Calikoglu, Cynthia M. Powell> ;American Journal of Medical Genetics. Part A. 2017 Jul 27
• 45 citations
  Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia
  Sander M. Houten, Simone Denis, Heleen te Brinke, Aldo Jongejan, Antoine H. C. van Kampen, Edward J. Bradley, Frank Baas, Raoul C.M. Hennekam, David S. Millington, Sar...> ;Human Molecular Genetics. 2014 Sep 15
• 151 citations
  Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
  Joseph Muenzer, Michael Beck, Christine M. Eng, Roberto Giugliani, Paul Harmatz, Rick A. Martin, Uma Ramaswami, Ashok Vellodi, James E. Wraith, Maureen Cleary, Muge Gu...> ;Genetics in Medicine. 2011 Feb 1
• 64 citations
  Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformat...
  Christian Kranz, Alice Basinger, Muge Gucsavas-Calikoglu, Liangwu Sun, Cynthia M. Powell, Frederick W. Henderson, Arthur S. Aylsworth, Hudson H. Freeze> ;American Journal of Medical Genetics. Part A. 2007 Jun 15
• 156 citations
  A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome).
  Joseph Muenzer, Muge Gucsavas-Calikoglu, Shawn E. McCandless, Thomas J Schuetz, Alan Kimura> ;Molecular Genetics and Metabolism. 2007 Mar 1
• 420 citations
  A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
  Joseph Muenzer, James E. Wraith, Michael Beck, Roberto Giugliani, Paul Harmatz, Christine M. Eng, Ashok Vellodi, Rick A. Martin, Uma Ramaswami, Muge Gucsavas-Calikoglu...> ;Genetics in Medicine. 2006 Jul 30
• 1 citations
  A clinical report of a patient with two abnormal cell lines: 46,XX,del(21)(q22.1) and 47,XX,+3
  Denise I. Quigley, Jeffery Sailus, Kathleen Kaiser-Rogers, Kathleen W. Rao, Muge Gucsavas Calikoglu, Stuart H. Gold, Shawn E. McCandless> ;American Journal of Medical Genetics. Part A. 2005 Jan 1
• Join now to see all